Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 2
Submit an article Journal homepage
337
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Late relapse of primary central nervous system lymphoma

Ryuya Yamanakaa Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan;b Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanCorrespondence[email protected]
,
Ken Moriic Department of Neurosurgery, Kitanihon Neurosurgical Hospital, Gosen, Japan
,
Yoshikatsu Shinboa Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Masakazu Sanoa Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan;d Department of Neurosurgery, Shibata Prefectural Hospital, Shibata, Japan
,
Jumpei Hommaa Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan;e Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan
,
Naoto Tsuchiyaa Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan;f Department of Neurosurgery, Nagano Red Cross Hospital, Nagano, Japan
,
Naoki Yajimaa Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Yoshihiro Tsukamotoa Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Ryouske Oguraa Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Manabu Natsumedaa Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Hiroshi Aokia Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Katsuhiko Akiyamag Department of Neurosurgery, Uonuma-Kikan Hospital, Minamiuonuma, Japan
,
Takafumi Saitohf Department of Neurosurgery, Nagano Red Cross Hospital, Nagano, Japan
,
Tetsuro Tamurah Department of Neurosurgery, Niigata Prefectural Central Hospital, Joetsu, Japan
,
Hiroaki Hondohe Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan
,
Atsushi Kawaguchii Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University, Saga, Japan
,
Hitoshi Takahashij Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan
&
Yukihiko Fujiia Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
 show all
Pages 475-477 | Received 21 Feb 2016, Accepted 05 Jun 2016, Published online: 10 Jul 2016

References

  • Panageas KS, Elkin EB, DeAngelis LM, et al. Trends in survival from primary central nervous system lymphoma, 1975–1999: a population-based analysis. Cancer. 2005;104:2466–2472.
  • Ferreri AJ, Reni M, Foppoli M, et al. International Extranodal Lymphoma Study Group (IELSG), et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet. 2009;374:1512–1520.
  • Thiel E, Korfel A, Martus P, et al. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol. 2010;11:1036–1047.
  • Morris PG, Correa DD, Yahalom J, et al. Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol. 2013;31:3971–3979.
  • Yamanaka R, Morii K, Shinbo Y, et al. Results of treatment of 112 cases of primary CNS lymphoma. Jpn J Clin Oncol. 2008;38:373–380.
  • Gavrilovic IT, Hormigo A, Yahalom J, et al. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol. 2006;24:4570–4574.
  • Kasenda B, Schorb E, Fritsch K, et al. Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma–a long-term follow-up study. Ann Oncol. 2012;23:2670–2675.
  • Ferreri AJ, Ciceri F, Brandes AA, et al. MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years. Neurology. 2014;82:1370–1373.
  • Herrlinger U, Hebart H, Kanz L, et al. Relapse of primary CNS lymphoma after more than 10 years in complete remission. J Neurol. 2005;252:1409–1410.
  • Nayak L, Hedvat C, Rosenblum MK, et al. Late relapse in primary central nervous system lymphoma: clonal persistence. Neuro Oncol. 2011;13:525–529.
  • Provencher S, Ferlay C, Alaoui-Slimani K, et al. Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series. Hematol Oncol. 2011;29:10–16.
  • Riemersma SA, Jordanova ES, Schop RF, et al. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood. 2000;96:3569–3577.
  • O'Neill BP, Dinapoli RP, Kurtin PJ, et al. Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough? J Neurooncol. 1995;25:67–71.
  • Hoang-Xuan K, Bessell E, Bromberg J, et al. European association for neuro-oncology task force on primary CNS lymphoma diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 2015;16:e322–e332.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.